Fitzgerald Kevin Joseph's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Nov 19, 2025
- Accession no.
- 0001735276-25-000123
- Filed
- Nov 19, 2025
- Trade date
- Nov 17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.48M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fitzgerald Kevin JosephCIK 0001886431 | Officer (CSO & EVP, Head of Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | MOption exerciseAcquired | +8,161 | $119.13 | +$972,219.93 | 33,392 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −8,168 | $449.00 | −$3,667,432 | 25,224 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −96 | $450.09 | −$43,208.64 | 25,128 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −129 | $451.51 | −$58,244.79 | 24,999 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −368 | $455.24 | −$167,528.32 | 24,631 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −364 | $456.25 | −$166,075 | 24,267 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −262 | $457.39 | −$119,836.18 | 24,005 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −794 | $458.41 | −$363,977.54 | 23,211 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −622 | $459.89 | −$286,051.58 | 22,589 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −707 | $460.84 | −$325,813.88 | 21,882 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −323 | $461.96 | −$149,213.08 | 21,559 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −295 | $463.08 | −$136,608.6 | 21,264 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | MOption exerciseDisposed | −8,161 | $0.00 | $0 | 839 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.